Defb14 - defensin beta 14

Predicted to enable CCR6 chemokine receptor binding activity and chemoattractant activity. Predicted to be involved in antimicrobial humoral immune response mediated by antimicrobial peptide; cell chemotaxis; and defense response to other organism. Predicted to be active in extracellular space. Orthologous to human DEFB103A (defensin beta 103A). [provided by Alliance of Genome Resources, Apr 2022]